Affymax Once-Monthly ESA Will Target Smaller Dialysis Centers
This article was originally published in The Pink Sheet Daily
Executive Summary
Omontys (peginesatide) launches for chronic kidney disease patients on dialysis, while non-dialysis patients were not included in the labeling due to CV event risk. Pricing negotiations will commence following the March 27 approval.